Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review

Over the last two decades, there has been significant progress in the treatment of metastatic prostate cancer. Multiple treatments with diverse mechanisms of action have improved clinical outcomes for patients with metastatic castration-resistant prostate cancer (mCRPC) including taxane chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurice Dror, Corinne, Chi, Kim N., Khalaf, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Management of Advanced Genitourinary Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575566/
https://www.ncbi.nlm.nih.gov/pubmed/34804836
http://dx.doi.org/10.21037/tau-20-1341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575566/
https://www.ncbi.nlm.nih.gov/pubmed/34804836
http://dx.doi.org/10.21037/tau-20-1341

Ejemplares similares